Running Away Balloon
Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The IndependentEvidence WatchDaily Digest 2026-03-08CED Clinic BlogCannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years…
Daily Digest: Last 19 Hours: CHS on the Rise, Hospital Cannabis Bills Advance, and Athletes Rethink Painkillers — March 02, 2026
This digest highlights hospital cannabis use legislation advances alongside rising awareness of cannabinoid analgesia for athletes. It also covers the increasing recognition of cannabis hyperemesis syndrome. These topics underscore evolving clinical and…
Evidena Care Launches Switzerland’s First Integrated Medical Cannabis Market
The integrated medical cannabis market in Switzerland marks a regulatory milestone improving cannabis medicine distribution. This market enhances product standardization and clinical documentation. Swiss clinicians now have a regulated framework for…
Bills on Cannabis Use in Hospitals Advance in Several States (Newsletter: March 2, 2026)
Hospital cannabis use legislation is advancing in multiple states, signaling a shift toward integrating medical cannabis in inpatient care. These laws aim to allow patients to continue cannabis treatment during hospitalization, improving symptom…
Rising Cases of Cannabis Hyperemesis Syndrome Across the US
Cannabis hyperemesis syndrome cases surge nationwide as chronic cannabis use increases. This syndrome causes cyclic nausea, vomiting, and abdominal pain in users. Early recognition and cannabis cessation are critical for effective management.
Daily Digest: Last 24 Hours: Pain, Policy, and the Psychiatric Tradeoffs of Cannabis — March 01, 2026
This digest covers 2026 cannabis psychiatric tradeoffs with a focus on pain management and policy developments. It synthesizes recent articles to provide clinical context. Dr. Caplan offers insights on balancing therapeutic benefits and psychiatric risks.
Daily Digest: Last 8 Hours: Pain, Policy, and the Psychiatric Tradeoffs of Cannabis – March 01, 2026
Cannabis medicine maturation is reshaping pain management and psychiatric care. This digest reviews recent evidence on cannabis as an opioid alternative and its psychiatric tradeoffs. Clinicians must balance benefits and risks with precision in this…
UNO Draw 25
Or you could talk to a cannabis doctor / Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The IndependentEvidence WatchDaily Digest 2026-03-08CED Clinic BlogCannabis-Infused Beverages as Alcohol…
Cannabinoid Beverage Substitution: What New York’s Data Reveals
Recent clinical research on cannabinoid beverage substitution reveals measurable changes in alcohol consumption patterns. Adults choosing cannabinoid beverages over alcohol may experience different health outcomes. This emerging data informs…
Link Between Cannabis and Anxiety, Depression Strengthens Over Time
Recent studies reveal a strengthening cannabis anxiety link that challenges previous perceptions of cannabis as a benign anxiolytic. This evolving evidence suggests cannabis may exacerbate mood disorders like anxiety and depression. Clinicians should…